2022-07-01 2023-06-30 false Capium Accounts Production 1.1 11435481 bus:FullAccounts 2022-07-01 2023-06-30 11435481 bus:Micro-entities 2022-07-01 2023-06-30 11435481 bus:AuditExempt-NoAccountantsReport 2022-07-01 2023-06-30 11435481 bus:SmallCompaniesRegimeForAccounts 2022-07-01 2023-06-30 11435481 bus:PrivateLimitedCompanyLtd 2022-07-01 2023-06-30 11435481 2022-07-01 2023-06-30 11435481 2023-06-30 11435481 bus:RegisteredOffice 2022-07-01 2023-06-30 11435481 core:WithinOneYear 2023-06-30 11435481 core:AfterOneYear 2023-06-30 11435481 bus:Director1 2022-07-01 2023-06-30 11435481 bus:Director1 2023-06-30 11435481 bus:Director1 2021-07-01 2022-06-30 11435481 2021-07-01 11435481 bus:CompanySecretary1 2022-07-01 2023-06-30 11435481 bus:LeadAgentIfApplicable 2022-07-01 2023-06-30 11435481 2021-07-01 2022-06-30 11435481 2022-06-30 11435481 core:WithinOneYear 2022-06-30 11435481 core:AfterOneYear 2022-06-30 11435481 bus:EntityAccountantsOrAuditors 2021-07-01 2022-06-30 11435481 core:CostValuation core:Non-currentFinancialInstruments 2023-06-30 11435481 core:CostValuation core:Non-currentFinancialInstruments 2022-06-30 11435481 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2023-06-30 11435481 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2023-06-30 11435481 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2023-06-30 11435481 core:Non-currentFinancialInstruments 2023-06-30 11435481 core:Non-currentFinancialInstruments 2022-06-30 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 11435481
England and Wales

 

 

 

MEDEX THERAPY LIMITED


Unaudited Filleted Financial Statements
 


Period of accounts

Start date: 01 July 2022

End date: 30 June 2023
  2023   2022
    £ £   £ £
Current assets 106,813      107,065   
Creditors: amount falling due within one year (78,852)     (79,637)  
Net current assets   27,961      27,428 
Total assets less current liabilities   27,961      27,428 
Accruals and deferred income   (450)     (450)
Net assets   27,511      26,978 
 

         
Capital and reserves   27,511      26,978 
 
NOTES TO THE ACCOUNTS

General Information
Medex Therapy Limited is a private company, limited by shares, registered in England and Wales, registration number 11435481, registration address 2 Garforth Rise, Bolton, BL1 5JL. The trading address of the company is Unit 6, Chulsey Street, Bolton, BL1 5JL.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
2.

Average number of employees

Average number of employees during the year was 1 (2022 : 1).


For the year ended 30 June 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's Responsibilities:
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.

The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the director on 29 March 2024 and were signed by:


--------------------------------
Shirin Ishak Jarman
Director
1